Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$81.92 -0.6 | -0.73%
01/19/17 - 10:27 AM ET
Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -588.18M -742.75M -687.55M -51.13M
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -104.85M 7.43M 53.36M 39.91M
(Increase) Decrease in Inventories -23.15M -16.47M 7.14M -29.93M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -1.71M 25.05M -49.23M 14.89M
(Decrease) Increase In Other Current Liabilities 72.25M -45.68M 39.65M 26.25M
(Increase) Decrease In Other Working Capital -19.24M -25.53M -53.01M -39.32M
Other Non-Cash Items 243.07M 177.07M 877.72M 255.94M
Net Cash From Continuing Operations -365.43M -573.11M -60.67M 267.84M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -365.43M -573.11M -60.67M 267.84M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 1.07B 1.56B 2.35B 1.37B
Purchases of Property, Plant & Equipment -125.30M -61.20M -51.39M -71.14M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -633.04M -1.42B -2.41B -1.71B
Other Cash from Investing Activities -10.24M 9.44M 2.96M -16.77M
Cash Provided by Financing Activities
Net Cash From Investing Activities 268.86M 82.01M -112.56M -425.82M
Issuance of Debt 0.00 294.24M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 185.59M 274.62M 265.88M 191.72M
Repayment of Long-Term Debt -20.34M -21.78M -16.21M -21.49M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 23.66M 2.16M -1.25M 1.97M
Net Cash From Financing Activities 188.92M 549.24M 248.41M 172.20M
Effect of Exchange Rate Changes -2.83M -2.18M 4.71M -141.00K
Net Change in Cash & Cash Equivalents 89.51M 55.96M 79.89M 14.09M

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter